TreatmentThere are currently no ant

Treatment
There are currently no antiviral drugs or vaccines available to
treat Nipah virus infection for either people or animals. Intensive
supportive care with treatment of symptoms is the main approach
to managing the infection in people. Experimentally, the therapeutic
use of a neutralizing human monoclonal antibody, the m102.4, which
recognizes the receptor binding domain of the NiV G glycoproteins,
appeared promising in a ferret animal model [21]. Furthermore, the
m102.4 was also successfully tested in Non Human Primate (NHP)
models against challenge with related Hendra virus [60].
Prevention
There is no vaccine against Nipah virus. A number of researches
have been successfully conducted on the development of vaccines
[61,62]. Experiments have been conducted also in African green
monkeys [63]. However, results are limited to experimental condition
and further progress is required to obtain protection against NiV in
humans and animals. Only recently, a vaccine for the prevention of
Hendra virus in horses has been licensed in Australia by Pfizer Animal
Health under the name Equivac
®
HeV [64].
To date, prevention of Nipah virus infection relies on veterinary
measures in domestic animals and public health education.

Hasil (Bahasa Indonesia) 1:

PengobatanAda saat ini tidak ada obat-obat antivirus atau vaksin tersedia untuk mengobati infeksi virus Nipah untuk orang-orang atau hewan. Intensif dukungan perawatan suportif dengan pengobatan gejala adalah pendekatan utama untuk mengelola infeksi pada orang. Eksperimental, terapi penggunaan menetralkan manusia monoclonal antibodi, m102.4, yang mengakui domain mengikat reseptor NiV G glikoprotein, muncul menjanjikan dalam model hewan ferret [21]. Selain itu, M102.4 ini juga berhasil diuji di bebas manusia primata (NHP) model terhadap tantangan dengan terkait virus Hendra [60].PencegahanAda tidak ada vaksin terhadap Nipah virus. Sejumlah penelitian telah berhasil dilakukan pada pengembangan vaksin [61,62]. percobaan yang telah dilakukan juga di Afrika green monyet [63]. Namun, hasil terbatas pada kondisi eksperimental dan lebih lanjut kemajuan diperlukan untuk memperoleh perlindungan terhadap NiV di manusia dan hewan. Baru-baru ini, vaksin untuk pencegahan Virus Hendra di kuda telah dilisensikan di Australia oleh Pfizer hewan Kesehatan di bawah nama Equivac® HeV [64].Sampai saat ini, pencegahan Nipah infeksi virus bergantung pada hewan langkah-langkah dalam hewan domestik dan pendidikan kesehatan masyarakat.